{
    "applicationNumber": "BR 11 2021 006423-0",
    "filingDate": "02/10/2019",
    "grantDate": null,
    "title": "DERIVADOS DE AZITROMICINA E ROXITROMICINA COMO F\u00c1RMACOS SENOL\u00cdTICOS",
    "nationalPhaseDate": [
        "01/04/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2019/054231",
        "pctDate": "02/10/2019",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/740,137",
            "priorityDate": "02/10/2018"
        },
        {
            "countryCode": "US",
            "priorityNumber": "62/750,559",
            "priorityDate": "25/10/2018"
        },
        {
            "countryCode": "US",
            "priorityNumber": "62/788,187",
            "priorityDate": "04/01/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2623"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2635"
        }
    ],
    "inventors": [
        "FEDERICA SOTGIA",
        "MICHAEL P LISANTI"
    ],
    "holders": [
        250425
    ],
    "ipcCodes": [
        "A61P 31/04",
        "A61K 31/7048",
        "A61K 31/7042"
    ]
}